Clinical Trial Update: Interleukin-12 in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating interleukin-12 in patients with multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED